Despite PGD2 being identified as a tumor-suppressive factor by numerous studies, most research has been based on in vitro experiments, with the underlying mechanisms remaining insufficiently explored (Iwanaga et al., 2014; Zhang et al., 2024; Omori et al., 2018). This evidence concerns the gene HPGDS and neoplasm.